EP Patent

EP3861857A1 — Antiparasitic compositions

Assigned to Novaliq GmbH · Expires 2021-08-11 · 5y expired

What this patent protects

The present invention relates to an antiparasitic composition comprising an antiparasitic agent and a semifluorinated alkane.

USPTO Abstract

The present invention relates to an antiparasitic composition comprising an antiparasitic agent and a semifluorinated alkane.

Drugs covered by this patent

Xeglyze (ABAMETAPIR) · Hatchtech

Patent Metadata

Patent number: EP3861857A1
Jurisdiction: EP
Classification: —
Expires: 2021-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Novaliq GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.